Overactive Bladder - Results from #2040

Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: Results from a randomised European-Australian phase 3 trial - Abstract December 7, 2012

Five years follow-up study and failures analysis of botulinum toxin repeated injections to treat neurogenic detrusor overactivity - Abstract December 6, 2012

Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder - Abstract December 6, 2012

Cost-effectiveness analysis of anti-muscarinic agents for the treatment of overactive bladder - Abstract December 6, 2012

Clinical findings associated with bladder trabeculations in women - Abstract December 4, 2012

Urinary neurotrophic factors in healthy individuals and patients with overactive bladder - Abstract December 4, 2012

Lower urinary tract symptoms in patients with Niigata Minamata disease: A case-control study 50 years after methyl mercury pollution - Abstract December 3, 2012

Unconventional treatment procedures of the bladder in paraplegia and myelomeningocele - Abstract December 1, 2012

Persistent genital arousal disorder: Characterization, etiology, and management - Abstract November 30, 2012

Vesicoureteral reflux in overactive bladder: Medical resolution through botulin toxin injection - Abstract November 28, 2012

Sacral nerve stimulation for urinary dysfunction: The first year of the Scottish national service - Abstract November 21, 2012

Detrusor overactivity in diabetic and non-diabetic patients: Is there a difference? - Abstract November 20, 2012

Overactive bladder syndrome - management and treatment options - Abstract November 19, 2012

Correlation between cystometric volumes, ATP release, and pH in women with overactive bladder versus controls - Abstract November 16, 2012

Burden of overactive bladder symptom on quality of life in stroke patients - Abstract November 16, 2012

Medical management of overactive bladder - Abstract November 14, 2012

Relationship between overactive bladder and irritable bowel syndrome: A large-scale internet survey in Japan using the overactive bladder symptom score and Rome III criteria - Abstract November 12, 2012

FDA panel splits on Merck plan to sell bladder drug over-the-counter November 9, 2012

Predicting self-perceived antimuscarinic therapy effectiveness on overactive bladder symptoms using the Overactive Bladder 8-Question Awareness Tool - Abstract November 9, 2012

Botulinum toxin in neurogenic detrusor overactivity - Abstract November 7, 2012

Page 103 of 122